Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Cyclophosphamide

Adverse events associated with cyclophosphamide: A pharmacovigilance study using the FDA adverse event reporting system

Hui Zhang, Minghao Lin, Dexi Zhao, Yujuan Fu

published 06 Jan 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Conditional deletion of Tmem63b does not impact mouse voiding behavior

Marianela G. Dalghi, Wily G. Ruiz, Dennis R. Clayton, Tanmay Parakala-Jain, Marcelo D. Carattino, Yun Stone Shi, Gerard Apodaca

published 05 Dec 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Population interest in and adequacy of the information on the safety of antineoplastic agents in the Spanish edition of Wikipedia

Seira Climent-Ballester, Pedro García-Salom, Javier Sanz-Valero

published 22 Apr 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis

Zhi Yong Wong, Chiu Yee Teo, Yan Qi Fiona Wong, Ka Ting Ng, Soo Kun Lim

published 31 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Ingrid G. Rekeland, Kari Sørland, Lisbeth Lykke Neteland, Alexander Fosså, Kine Alme, Kristin Risa, Olav Dahl, Karl J. Tronstad, Olav Mella, Øystein Fluge

published 23 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Classifying invasive lobular carcinoma as special type breast cancer may be reducing its treatment success: A comparison of survival among invasive lobular carcinoma, invasive ductal carcinoma, and no-lobular special type breast cancer

Rusen Cosar, Necdet Sut, Sernaz Topaloglu, Ebru Tastekin, Dilek Nurlu, Talar Ozler, Eylül Şenödeyici, Melisa Dedeli, Mert Chousein, Irfan Cicin

published 10 Jul 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Lida Zafeiri, Torbjörn Åkerfeldt, Andreas Tolf, Kristina Carlson, Alkistis Skalkidou, Joachim Burman

published 12 Apr 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM

Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, Youngil Koh, Sock-Won Yoon, Dong-Yeop Shin, Junshik Hong, Inho Kim

published 27 Jan 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients

Faouzi Djebbari, Alexandros Rampotas, Fotios Panitsas, Wen Yuen Lim, Charlotte Lees, Ismini Tsagkaraki, Ana Rita Gomes, Steve Prideaux, Lucia Chen, Catherine Prodger, Akhil Khera, Nicola Gray, Lauren Ellis, Gina Sangha, Toby A. Eyre, Sally Moore, Jaimal Kothari, Karthik Ramasamy

published 11 Jan 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement

Mélanie Bézard, Silvia Oghina, Damien Vitiello, Mounira Kharoubi, Ekaterini Kordeli, Arnault Galat, Amira Zaroui, Soulef Guendouz, Floriane Gilles, Jason Shourick, David Hamon, Vincent Audard, Emmanuel Teiger, Elsa Poullot, Valérie Molinier-Frenkel, François Lemonnier, Onnik Agbulut, Fabien Le Bras, Thibaud Damy

published 15 Sep 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis

Ben Ponvilawan, Smith Kungwankiattichai, Nipith Charoenngam, Weerapat Owattanapanich

published 28 Jun 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models

Kiyomi Mashima, Iekuni Oh, Ken Fujiwara, Junko Izawa, Norihito Takayama, Hirofumi Nakano, Yasufumi Kawasaki, Daisuke Minakata, Ryoko Yamasaki, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin-Ichiro Fujiwara, Nobuhiko Ohno, Yoshinobu Kanda

published 11 Jan 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Cardiac sarcoidosis: A long term follow up study

Patrice Cacoub, Catherine Chapelon-Abric, Matthieu Resche-Rigon, David Saadoun, Anne Claire Desbois, Lucie Biard

published 18 Sep 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Cyclophosphamide

You can change these options by clicking profile then "Alerts and Notifications"